Literature DB >> 20881232

Functional genetic variants in the 3'-untranslated region of sulfotransferase isoform 1A1 (SULT1A1) and their effect on enzymatic activity.

Xinfeng Yu1, Ishwori B Dhakal, Marjorie Beggs, Vineetha Koroth Edavana, Suzanne Williams, Xuemei Zhang, Kelly Mercer, Baitang Ning, Nicholas P Lang, Fred F Kadlubar, Susan Kadlubar.   

Abstract

Sulfotransferase isoform 1A1 (SULT1A1) is the most highly expressed hepatic sulfotransferase and is involved in the biotransformation of a wide variety of endo- and xenobiotics. A common single nucleotide polymorphism (SNP) in the coding region of SULT1A1, several proximal promoter SNPs, and copy number variation (CNV) are associated with altered enzymatic activity, but these variants do not fully account for the observed variation of SULT1A1 activity in human populations. In order to identify additional SNPs modulating SULT1A1 activity, we examined the 3'-untranslated region (UTR) of SULT1A1 in 97 liver samples. Direct sequencing revealed that two SNPs in the 3'-UTR (902A > G [rs6839] and 973C > T [rs1042157]) and one SNP in the 3'-flanking region (1307G > A [rs4788068]) were common. These SNPs are in absolute linkage disequilibrium with each other and in tight linkage with SULT1A1 1/2 (linkage coefficient D' 0.83) and are significantly associated with SULT1A1 messenger RNA (p = 0.001, 0.029, 0.021) and enzymatic activity (p = 0.022, 0.012, 0.027). We then examined the collective effects of 3'-UTR SNPs, SULT1A1 1/2, and CNV on SULT1A1 activity in 498 Caucasian and 127 African-American subjects by haplotype analysis. This analysis revealed that SULT1A1 1/2 does not contribute to the variation in SULT1A1 enzymatic activity when the 3'-UTR SNPs are included in the statistical model. Two major haplotypes (ACG and GTA) were significantly correlated with SULT1A1 activity, and when stratified by copy number, the SULT1A1 3'-UTR SNPs remain significantly associated with SULT1A1 enzymatic activity in Caucasians, but not in African-Americans. Subsequent functional characterization revealed that a microRNA, miR-631, regulates SULT1A1 expression in a genotype-specific manner.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20881232      PMCID: PMC2984532          DOI: 10.1093/toxsci/kfq296

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  42 in total

Review 1.  The enzymes of detoxication.

Authors:  W B Jakoby; D M Ziegler
Journal:  J Biol Chem       Date:  1990-12-05       Impact factor: 5.157

2.  Generation of reactive metabolites of N-hydroxy-phenacetin by glucoronidation and sulfation.

Authors:  G J Mulder; J A Hinson; J R Gillette
Journal:  Biochem Pharmacol       Date:  1977-02-01       Impact factor: 5.858

3.  Human intestinal phenol sulfotransferase: assay conditions, activity levels and partial purification of the thermolabile form.

Authors:  R S Sundaram; C Szumlanski; D Otterness; J A van Loon; R M Weinshilboum
Journal:  Drug Metab Dispos       Date:  1989 May-Jun       Impact factor: 3.922

Review 4.  Inhibition of human liver and duodenum sulfotransferases by drugs and dietary chemicals: a review of the literature.

Authors:  G M Pacifici
Journal:  Int J Clin Pharmacol Ther       Date:  2004-09       Impact factor: 1.366

5.  Genetic polymorphism for human platelet thermostable phenol sulfotransferase (TS PST) activity.

Authors:  R A Price; R S Spielman; A L Lucena; J A Van Loon; B L Maidak; R M Weinshilboum
Journal:  Genetics       Date:  1989-08       Impact factor: 4.562

6.  Human liver phenol sulfotransferase: assay conditions, biochemical properties and partial purification of isozymes of the thermostable form.

Authors:  N R Campbell; J A Van Loon; R M Weinshilboum
Journal:  Biochem Pharmacol       Date:  1987-05-01       Impact factor: 5.858

7.  Inheritance of human platelet thermolabile phenol sulfotransferase (TL PST) activity.

Authors:  R A Price; N J Cox; R S Spielman; J A Van Loon; B L Maidak; R M Weinshilboum
Journal:  Genet Epidemiol       Date:  1988       Impact factor: 2.135

8.  The human phenolsulphotransferase polymorphism is determined by the level of expression of the enzyme protein.

Authors:  A L Jones; R C Roberts; M W Coughtrie
Journal:  Biochem J       Date:  1993-12-01       Impact factor: 3.857

9.  Human platelet phenol sulfotransferase: familial variation in thermal stability of the TS form.

Authors:  J Van Loon; R M Weinshilboum
Journal:  Biochem Genet       Date:  1984-12       Impact factor: 1.890

10.  Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine.

Authors:  I Johansson; E Lundqvist; L Bertilsson; M L Dahl; F Sjöqvist; M Ingelman-Sundberg
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

View more
  37 in total

Review 1.  MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy.

Authors:  Ai-Ming Yu; Ye Tian; Mei-Juan Tu; Pui Yan Ho; Joseph L Jilek
Journal:  Drug Metab Dispos       Date:  2015-11-13       Impact factor: 3.922

2.  miRNA-324, a potential therapeutic target for paracetamol-induced liver injury.

Authors:  Hong Min Wu; Sang Geon Kim
Journal:  Stem Cell Investig       Date:  2016-10-25

3.  Multi-ethnic SULT1A1 copy number profiling with multiplex ligation-dependent probe amplification.

Authors:  Raymon Vijzelaar; Mariana R Botton; Lisette Stolk; Suparna Martis; Robert J Desnick; Stuart A Scott
Journal:  Pharmacogenomics       Date:  2018-05-23       Impact factor: 2.533

Review 4.  Sulfotransferase genetic variation: from cancer risk to treatment response.

Authors:  Jaclyn Daniels; Susan Kadlubar
Journal:  Drug Metab Rev       Date:  2013-09-06       Impact factor: 4.518

5.  MicroRNA hsa-miR-29a-3p modulates CYP2C19 in human liver cells.

Authors:  Dianke Yu; Bridgett Green; William H Tolleson; Yaqiong Jin; Nan Mei; Yongli Guo; Helen Deng; Igor Pogribny; Baitang Ning
Journal:  Biochem Pharmacol       Date:  2015-08-19       Impact factor: 5.858

Review 6.  The effects of microRNA on the absorption, distribution, metabolism and excretion of drugs.

Authors:  Y He; J R Chevillet; G Liu; T K Kim; K Wang
Journal:  Br J Pharmacol       Date:  2014-12-01       Impact factor: 8.739

7.  Relationship of SULT1A1 copy number variation with estrogen metabolism and human health.

Authors:  Jixia Liu; Ran Zhao; Zhan Ye; Alexander J Frey; Emily R Schriver; Nathaniel W Snyder; Scott J Hebbring
Journal:  J Steroid Biochem Mol Biol       Date:  2017-09-01       Impact factor: 4.292

8.  Pharmacogenetics of SULT1A1.

Authors:  Jaclyn Daniels; Susan Kadlubar
Journal:  Pharmacogenomics       Date:  2014-11       Impact factor: 2.533

9.  A systematic evaluation of microRNAs in regulating human hepatic CYP2E1.

Authors:  Yong Wang; Dianke Yu; William H Tolleson; Li-Rong Yu; Bridgett Green; Linjuan Zeng; Yinting Chen; Si Chen; Zhen Ren; Lei Guo; Weida Tong; Huaijin Guan; Baitang Ning
Journal:  Biochem Pharmacol       Date:  2017-04-22       Impact factor: 5.858

10.  Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development: the example of the novel anticancer agent ABT-751.

Authors:  Federico Innocenti; Jacqueline Ramírez; Jennifer Obel; Julia Xiong; Snezana Mirkov; Yi-Lin Chiu; David A Katz; Robert A Carr; Wei Zhang; Soma Das; Araba Adjei; Ann M Moyer; Pei Xian Chen; Andrew Krivoshik; Diane Medina; Gary B Gordon; Mark J Ratain; Leonardo Sahelijo; Richard M Weinshilboum; Gini F Fleming; Anahita Bhathena
Journal:  Pharmacogenet Genomics       Date:  2013-07       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.